Immunovia AB (IMMNOV) Stock Statistics & Valuation Metrics

Immunovia AB has a market cap or net worth of $145.08M. The enterprise value is kr93.16M.

Immunovia AB has 306,083,070 shares outstanding. The number of shares has decreased by -2.65% in one year.

Immunovia AB’s return on equity (ROE) is -6.57 and return on invested capital (ROIC) is -887.43%.

The current PE Ratio of Immunovia AB is ―. Immunovia AB’s PEG ratio is ―.

In the last 12 months, Immunovia AB had revenue of 931.00K and earned -76.54M in profits. Earnings per share was -0.93.

In the last 12 months, operating cash flow was -88.13M and capital expenditures 0.00, giving a free cash flow of -88.13M billion.

Immunovia AB pays an annual dividend of ―, resulting in a dividend yield of ―

Immunovia AB upcoming earnings date is Nov 19, 2025, Before Open (Confirmed).

Immunovia AB as a current ratio of 1.34, with Debt / Equity ratio of 2.63%

In the past 12 months, Immunovia AB has paid 0.00 in taxes.

Immunovia AB EV to EBITDA ratio is -0.33, with an EV/FCF ratio of -0.21.

Immunovia AB has $29.27M in cash and marketable securities with $467.00K in debt, giving a net cash position of $28.80M billion.

Gross margin is -3218.61%, with operating margin of -11751.99%, and net profit margin of -8221.37%.

The average price target for Immunovia AB is ―, which is 11.43% higher than the current price. The consensus rating is ―